NCT02604667 (MOST-CA) is a clinical trial of Blood tests in Stroke, sponsored by Weill Medical College of Cornell University.

Who is sponsoring NCT02604667?

NCT02604667 is sponsored by Weill Medical College of Cornell University.

What drugs are being tested in NCT02604667?

Interventions in NCT02604667: Blood tests, Transcranial Doppler Microemboli Detection Study.

What condition does NCT02604667 study?

NCT02604667 studies Stroke, Cancer.

Is NCT02604667 still recruiting?

NCT02604667 is currently completed. Last updated 5 May 2021.

Last reviewed 2021-05-05 · How we verify

NCT02604667: MOST-CA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mechanisms of Ischemic Stroke in Cancer Patients

Completed Last updated 5 May 2021

What this trial tests

trial testing Blood tests in Stroke in 150 participants. Completed in 1 September 2020.

Timeline

8 April 2016

Primary endpoint
1 September 2020

1 September 2020

Quick facts

Lead sponsor	Weill Medical College of Cornell University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	150
Start date	8 April 2016
Primary completion	1 September 2020
Estimated completion	1 September 2020
Sites	2 locations across United States

Drugs / interventions tested

Blood tests — full drug profile →
Transcranial Doppler Microemboli Detection Study

Conditions studied

Stroke — all drugs for Stroke →
Cancer — all drugs for Cancer →

Sponsor

Weill Medical College of Cornell University

Who can join

18 and older, any sex, with Stroke or Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to better understand the causes of stroke in people with cancer. Active cancer increases the risk of stroke. The investigators do not know exactly why this occurs but one possible reason is that people with cancer may have thicker blood than people without cancer. Thick blood can sometimes cause blood clots to form in the heart, which can then travel to the brain and cause stroke. This study is being done to help figure out why this and other causes of stroke occur in people with cancer. The investigators expect that information from this study will help doctors to more effectively prevent and treat stroke in individuals with cancer.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Ischemic stroke in cancer patients: A review of an underappreciated pathology.
Navi BB, Iadecola C. · · 2018 · cited 206× · PMID 29633334 · DOI 10.1002/ana.25227
Cancer and Embolic Stroke of Undetermined Source.
Navi BB, Kasner SE, Elkind MSV, Cushman M, et al · · 2021 · cited 122× · PMID 33504187 · DOI 10.1161/strokeaha.120.032002
Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study.
Navi BB, Sherman CP, Genova R, Mathias R, et al · · 2021 · cited 58× · PMID 34029423 · DOI 10.1002/ana.26129
Ischemic stroke with cancer: Hematologic and embolic biomarkers and clinical outcomes.
Navi BB, Zhang C, Sherman CP, Genova R, et al · · 2022 · cited 24× · PMID 35652416 · DOI 10.1111/jth.15779
Cancer-Related Ischemic Stroke Has a Distinct Blood mRNA Expression Profile.
Navi BB, Mathias R, Sherman CP, Wolfe J, et al · · 2019 · cited 18× · PMID 31510897 · DOI 10.1161/strokeaha.119.026143

Verify or expand the search:

Other trials of Blood tests

Trials testing the same drug.

NCT06698614 — MEMRI and Kidney Disease · recruiting
NCT06630637 — Monitoring Intermittent Fasting for Human Optimization Using Wearable Technology: An N-of-1 Study · NA · completed
NCT06180278 — Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD) · Phase 4 · active not recruiting
NCT06156046 — Tolerance in Beekeepers · recruiting
NCT05208099 — Study of the Immunomodulation in the Hidradenitis Suppurativa and Evaluation of a New Therapeutic Strategy · not yet recruiting

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other Weill Medical College of Cornell University trials

Trials by the same sponsor.

NCT07485712 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 2 · NA · not yet recruiting
NCT05811338 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 1 · NA · not yet recruiting
NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT06818734 — Implementation of a Clinical Decision Support Tool for Postpartum Depression · NA · not yet recruiting
NCT07485725 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 3 · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02604667 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Weill Medical College of Cornell University
Last refreshed: 5 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02604667.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing